Derynck Mika K
SEC Form 4 insider trading activity
Derynck Mika K has filed 1 SEC Form 4 filing (5 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Aug 7, 2026.
On the most recent filing, Derynck Mika K is listed as Director at Enliven Therapeutics, Inc. Inside the rolling window, Derynck Mika K reported no open-market purchases and 1 open-market sale totaling $9.6M in ELVN.
Companies traded
Other insiders at ELVN
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$9.6M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Derynck Mika K made?
Derynck Mika K has filed 1 SEC Form 4 filing (5 transaction rows) across 1 company since 2026.
Which companies does Derynck Mika K trade?
Derynck Mika K has filed SEC Form 4 disclosures for 1 company, including ELVN.
When was Derynck Mika K's most recent SEC Form 4 filing?
Derynck Mika K's most recent SEC Form 4 filing on Tracefour is dated Aug 7, 2026.
What is Derynck Mika K's total buy and sell value in the current window?
Inside the rolling retention window, Derynck Mika K bought $0 and sold $9.6M based on SEC Form 4 filings.
What was Derynck Mika K's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 158,795 ELVN shares on 2026-08-04, worth $9.6M, per SEC Form 4 filings.